R C Ribeiro
Overview
Explore the profile of R C Ribeiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
3451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capela de Matos R, Othman M, Ferreira G, Monteso K, de Souza M, Rouxinol M, et al.
Cancer Genet
. 2022 Jan;
262-263:16-22.
PMID: 34974289
Intrachromosomal amplification of chromosome 21 (iAMP21) occurs in ∼2% of B-cell acute lymphoblastic leukemia (ALL) and is considered to confer a poor prognosis. The relapse risk is associated with therapy...
2.
Anacak Y, Zubizarreta E, Zaghloul M, Laskar S, Alert J, Gondhowiardjo S, et al.
Clin Oncol (R Coll Radiol)
. 2020 Nov;
33(4):e211-e220.
PMID: 33250288
Aims: Childhood cancer survival is suboptimal in most low- and middle-income countries (LMICs). Radiotherapy plays a significant role in the standard care of many patients. To assess the current status...
3.
Ribeiro R, Pikart T, Fouad H, Parreira M, Zanuncio J, Soares M, et al.
Braz J Biol
. 2018 Nov;
79(3):377-382.
PMID: 30484477
Brazil is a leading palm oil producer, but the defoliating caterpillars Opsiphanes invirae Hübner Brassolis sophorae L. (Lepidoptera: Nymphalidae) can reduce the productivity of this crop. The aim of this...
4.
Schwartz J, Wang S, Ma J, Lamprecht T, Walsh M, Song G, et al.
Leukemia
. 2017 May;
31(8):1827-1830.
PMID: 28487541
No abstract available.
5.
Inaba H, Pei D, Wolf J, Howard S, Hayden R, Go M, et al.
Ann Oncol
. 2017 Apr;
28(2):386-392.
PMID: 28426102
Background: Comprehensive studies on neutropenia and infection-related complications in patients with acute lymphoblastic leukemia (ALL) are lacking. Patients And Methods: We evaluated infection-related complications that were grade ≥3 on National...
6.
Fernandes F, Fernandes M, Costa N, Pereira R, Dos Santos A, Ribeiro R
Braz J Biol
. 2016 Nov;
77(3):655-656.
PMID: 27849253
No abstract available.
7.
Liu C, Yang W, Pei D, Cheng C, Smith C, Landier W, et al.
Clin Pharmacol Ther
. 2016 Aug;
101(3):373-381.
PMID: 27564568
We performed a genomewide association study (GWAS) of primary erythrocyte thiopurine S-methyltransferase (TPMT) activity in children with leukemia (n = 1,026). Adjusting for age and ancestry, TPMT was the only...
8.
Pui C, Pei D, Raimondi S, Coustan-Smith E, Jeha S, Cheng C, et al.
Leukemia
. 2016 Aug;
31(2):333-339.
PMID: 27560110
To determine the clinical significance of minimal residual disease (MRD) in patients with prognostically relevant subtypes of childhood acute lymphoblastic leukemia (ALL), we analyzed data from 488 patients treated in...
9.
Drenberg C, Paugh S, Pounds S, Shi L, Orwick S, Li L, et al.
Clin Pharmacol Ther
. 2015 Dec;
99(6):651-60.
PMID: 26663398
Using broad interrogation of clinically relevant drug absorption, distribution, metabolism, and excretion (ADME) genes on the DMET platform, we identified a genetic variant in SLCO1B1 (rs2291075; c.597C>T), encoding the transporter...
10.
Pui C, Pei D, Campana D, Cheng C, Sandlund J, Bowman W, et al.
Leukemia
. 2014 May;
28(12):2336-43.
PMID: 24781017
With improved contemporary therapy, we reassess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia (ALL) to determine when cure can be declared with a high degree of...